NCT07138417 Compassion-Based Family Intervention for Adolescents
| NCT ID | NCT07138417 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Beijing HuiLongGuan Hospital |
| Condition | Emotional Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2025-08-30 |
| Primary Completion | 2027-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2025-08-30 with a primary completion date of 2027-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Adolescents with emotional disorders (such as depression or anxiety) often experience distress that also affects their parents, creating a cycle of stress within the family. This study tests a new compassion-based family intervention designed to help both adolescents and their parents. The program includes six weekly sessions (120 minutes each). The study will recruit 60 parent-adolescent dyads. Half will receive the intervention immediately; the other half will wait 6 weeks before receiving it. We will measure changes in depression, anxiety, parenting stress, family relationships, and - using brain imaging (fNIRS) and heart rate monitors - how the intervention affects parent-child emotional and physiological synchrony. Assessments will take place before the intervention, right after, and at 3-month and 6-month follow-ups. The goal is to see whether this family-focused compassion program can improve mental health for both adolescents and their parents.
Eligibility Criteria
Inclusion Criteria: * the adolescent is aged 12-18 years * for the adolescent, required scores at enrollment: at least one of the following criteria is met (i) 17-item Hamilton Depression Rating Scale (HAMD-17) (Hamilton, 1960) total score ≥17 and ≤30, (ii) Hamilton Anxiety Rating Scale (HAMA) (Hamilton, 1959) total score ≥18 and ≤29; and in addition, the item 3 score of HAMD-17 (suicide) must be ≤2 * at least one parent is willing to participate * the adolescent has normal auditory and visual perception abilities and intellectual level * the participating parent has normal reading and writing ability * the adolescent has no history of manic episodes Exclusion Criteria: * the adolescent presents with psychotic symptoms, bipolar disorder, or schizophrenia * the parent suffers from a mental illness or psychological disorder * the adolescent or their parent has a history of substance abuse * the adolescent or their parent has a severe neurological disorder or major physical disease * the adolescent or their parent is assessed as having high suicide risk
Contact & Investigator
Dongmei Wang, Ph.D
PRINCIPAL INVESTIGATOR
Institute of Psychology, Chinese Academy of Science
Frequently Asked Questions
Who can join the NCT07138417 clinical trial?
This trial is open to participants of all sexes, aged 12 Years or older, up to 18 Years, studying Emotional Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07138417 currently recruiting?
Yes, NCT07138417 is actively recruiting participants. Contact the research team at wangdm@psych.ac.cn for enrollment information.
Where is the NCT07138417 trial being conducted?
This trial is being conducted at Hefei, China.
Who is sponsoring the NCT07138417 clinical trial?
NCT07138417 is sponsored by Beijing HuiLongGuan Hospital. The principal investigator is Dongmei Wang, Ph.D at Institute of Psychology, Chinese Academy of Science. The trial plans to enroll 60 participants.